These stocks are usually going up or down because of brokers upgraded or downgraded .If you are looking to day trade, you might want to check out the following stocks. I usually throw these on my watch list and monitor with resistance & support levels.You can also check previous stocks to buy reports- Right Here.
BMC Software (BMC), WNS Holdings (WNS), athenahealth (ATHN), ViroPharma (VPHM), Vertex Pharmaceuticals (VRTX), Vail Resorts (MTN) were upgraded or downgraded by analysts.
BMC Software (BMC) upgraded to Neutral from Underweight at JP Morgan .JP Morgan upgraded BMC Software citing valuation and maintains a $34 price target for shares.
WNS Holdings (WNS) upgraded to Outperform from Neutral at RW Baird.Baird upgraded WNS Holdings citing valuation, new sales momentum, and potential upside to estimates. Price target raised to $13 from $12.
athenahealth (ATHN) upgraded to Neutral from Sell at Citigroup (Friday). Citigroup upgraded athenahealth shares Friday morning citing valuation and upped its price target for the name to $52 from $40.
ViroPharma (VPHM) initiated with a Neutral at Goldman Target $26.
Vertex Pharmaceuticals (VRTX) upgraded to Top Pick from Sector Perform at RBC Capital.RBC Capital upgraded Vertex to its Top Pick based on expectations for increasing positive newsflow including Kalydeco approval and launch in April 1012, upcoming CF data, and valuation. Price target remains $48.
Vail Resorts (MTN) initiated with an Outperform at Credit Suisse Target $56
WNS Holdings (WNS) upgraded to Outperform from Neutral at RW Baird.Baird upgraded WNS Holdings citing valuation, new sales momentum, and potential upside to estimates. Price target raised to $13 from $12.
athenahealth (ATHN) upgraded to Neutral from Sell at Citigroup (Friday). Citigroup upgraded athenahealth shares Friday morning citing valuation and upped its price target for the name to $52 from $40.
ViroPharma (VPHM) initiated with a Neutral at Goldman Target $26.
Vertex Pharmaceuticals (VRTX) upgraded to Top Pick from Sector Perform at RBC Capital.RBC Capital upgraded Vertex to its Top Pick based on expectations for increasing positive newsflow including Kalydeco approval and launch in April 1012, upcoming CF data, and valuation. Price target remains $48.
Vail Resorts (MTN) initiated with an Outperform at Credit Suisse Target $56
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
